26
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9647 |
GX 201
GX-201 |
Sodium Channel | Membrane transporter/Ion channel |
GX 201 是选择性的 NaV1.7 抑制剂,其对 hNaV1.7 的 IC50 值为 <3.2 nM。 | |||
T27520 |
GX-395
GX 395 |
||
GX-395 is a novel Nav1.7 inhibitor. | |||
T27521 |
GX-936
GX 936,PF 05196233,PF05196233,GX936,PF-05196233 |
||
GX-936, a Nav1.7 inhibitor, inhibits Nav1.7 through a voltage-sensor trapping mechanism, likely by stabilizing inactivated states of the channel. | |||
T22829 |
GX-674
|
Sodium Channel | Membrane transporter/Ion channel |
GX-674 是一种具有高效和选择性的电压门控钠通道 1.7 (Nav1.7) 拮抗剂,在 -40 mV 时测得 IC50 值为 0.1 nM,可用于研究炎症和神经性疼痛。 | |||
T69915 |
GX-585
|
||
GX-585 is a novel potent inhibitor of NaV1.7 and highly selective against NaV1.5, having limited selectivity against NaV1.1 and NaV1.2. | |||
T1439 |
Lacidipine
SN-305,拉西地平,GX-1048,GR-43659X |
Apoptosis; Calcium Channel; Reactive Oxygen Species | Apoptosis; Immunology/Inflammation; Membrane transporter/Ion channel; Metabolism; NF-κB |
Lacidipine (SN-305) 是一种L 型钙离子通道阻断剂。 | |||
T80638 |
Glycinexylidide
GX |
MEK | MAPK |
Glycinexylidide (GX) 是一种 Lidocaine 的活性代谢物。作为有效的局部麻醉药,Lidocaine 可以通过阻断复杂电压依赖性的钠通道来发挥作用。此外,它还能抑制胃癌细胞生长、迁移和侵袭。GX 显示出在麻醉、癌症治疗和心血管疾病研究中的应用潜力。 | |||
T69914 |
Variegatic acid
|
||
Variegatic acid is a natural inhibitor of β-hexosaminidase release and tumor necrosis factor (TNF)-α secretion from rat basophilic leukemia (RBL 2H3) cells, with IC50 values of 10.4 μM and 16.8 μM, respectively, also inhibiting PKC β1 activity with an IC50 value of 36.2 μM. | |||
T1813 |
VGX-1027
VGX1027,VGX 1027,GIT 27 |
IL Receptor; TNF; Interleukin | Apoptosis; Immunology/Inflammation |
VGX-1027 (GIT 27) 是一种口服有效的异恶唑化合物,靶向巨噬细胞,减少促炎性介质 TNF-α、IL-1β和 IL-10 的产生,具有免疫调节特性。它通过限制细胞因子介导的免疫炎症而具有抗糖尿病作用。 | |||
T7768 |
RGX-104
RGX-104 free Acid |
Liver X Receptor | Metabolism |
RGX-104 (RGX-104 free Acid) 是一种口服具有活力的肝X 核激素受体激动剂,通过 ApoE 基因的转录激活调节先天免疫。 | |||
T5128 |
RGX-104 hydrochloride
SB742881,RGX-104 HCl,盐酸RGX-104 |
Liver X Receptor | Metabolism |
RGX-104 hydrochloride (SB742881) 是小分子LXR 激动剂,利用 ApoE 基因的转录激活,调节先天免疫。 | |||
T10268 |
AGX51
|
Others | Others |
AGX51 是 DNA 结合蛋白抑制剂 (ID) 的拮抗剂。 AGX51 治疗导致泛 Id 降解、细胞周期停滞和细胞死亡。 | |||
T7535 |
RGX-202
胍基丙酸,β-GPA,3-Guanidinopropionic Acid |
AMPK; PPAR | Chromatin/Epigenetic; DNA Damage/DNA Repair; Metabolism; PI3K/Akt/mTOR signaling |
RGX-202 (β-GPA) 是口服有活性的SLC6A8转运蛋白抑制剂。它在体内外均能够强烈地抑制肌酸输入,降低细胞内磷酸肌酸和 ATP 水平,诱导肿瘤凋亡,可于研究肿瘤。 | |||
T2293 |
SGX-523
|
Raf; p38 MAPK; c-Met/HGFR; Bcr-Abl | Angiogenesis; Cytoskeletal Signaling; MAPK; Tyrosine Kinase/Adaptors |
SGX523 是选择性的和 ATP 竞争性的MET 抑制剂 (IC50:4 nM)。它对 MET 的选择性其它他蛋白激酶高 1000 倍。它具有抗肿瘤特性。 | |||
T2661 |
TGX-221
TGX221 |
PI3K | PI3K/Akt/mTOR signaling |
TGX-221 是一种选择性的、高效的、细胞膜渗透的 PI3K p110β 抑制剂,常用于研究癌症。 | |||
T24873 |
TGX-115
TGX 115 |
PI3K | PI3K/Akt/mTOR signaling |
TGX-115是一种细胞渗透性和有效的PI 3-K 异构体p110β/p110δ抑制剂(对p110β IC50值为 0.13 μM, 对p110δ值为0.63 μM),是一种调节血小板粘附过程的酶,可抑制磷酸肌苷(PI)3-激酶,可用来治疗冠状动脉闭塞、中风、急性冠状动脉综合征、急性心肌梗塞、血管再狭窄、动脉硬化和不稳定心绞痛等心血管疾病 。 | |||
T74899 | GXH-II-052 | ||
GXH-II-052 是一种有效的二价 BET(bivalent bromodomain and extraterminal domain (BET))抑制剂。GXH-II-052 显示与 BRD4-1、BRD4-2、BRD4-T、BRDT-1、BRDT-2、BRDT-T 的结合潜力,Kd 值分别为 28、9.1、4.8、0.6、8.4、2.6 nM。GXH-II-052 显示出抗增殖活性。GXH-II-052 降低 c-Myc 的表达。 | |||
T79034 |
GXF-111
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
GXF-111是一种PROTAC分子,能够选择性促进BRD3与BRD4-L在细胞内的降解。该分子与BRD3BD1和BRD3BD2的结合亲和力显著,Ki值分别为11.97 nM和2.35 nM。GXF-111主要用于癌症研究领域。 | |||
T78352 |
N-acetylglucosamine-1-P uridyltransferase (AGX1)
GlcNAc1pUT |
||
N-acetylglucosamine-1-P uridyltransferase (AGX1) (GlcNAc1pUT) 是具有双功能乙酰转移酶/尿苷转移酶活性的原核生物专有酶。该酶能结合GlcNAc-1-P与UTP,催化合成UDP-GlcNAc的尿苷酰转移反应。 | |||
T71581 |
SGX393
|
||
SGX393 is an inhibitor of the CML mutant Bcr-AblT315I, thereby preempting in vitro resistance when combined with nilotinib or dasatinib. | |||
T28168 |
NGX-267
AF-267B,AF267B,AF 267B,NGX 267 |
||
NGX-267, a muscarinic M1 agonist, is used potentially for the treatment of Xerostomia, Alzheimer's disease and cognitive. | |||
T63578 |
Mrgx2 antagonist-1
|
||
Mrgx2 antagonist-1 是 Mrgx2 (Mas-related Gene X2) 的有效拮抗剂,能够用于研究 Mrgx2 介导的疾病和紊乱。 | |||
T28095 |
MrgX1-Activator-1
|
||
MrgX1-Activator-1 is a MrgX1 receptor activator. | |||
T24874 |
TGX-155
TGX 155,TGX155 |
||
TGX-155 is a selective PI3K inhibitor. | |||
TP1531 |
Guangxitoxin 1E
|
||
Guangxitoxin 1E acts as a gating modifier since it shifts the voltage-dependence of Kv2.1 K+ currents towards depolarized potentials. | |||
T38446 |
ROC-0929
|
||
ROC-0929 (compound 13a) is a potent and selective inhibitor of secreted phospholipases A2 (sPLA2s), effectively targeting hGX with an IC50 of 80 nM. It efficiently inhibits the phosphorylation of ERK1/2 and p-38. sPLA2s, belonging to the disulfide-rich, Ca2+-dependent enzyme family, catalyze the hydrolysis of glycero-phospholipids at the sn-2 position, resulting in the release of a fatty acid and a lysophospholipid. ROC-0929 holds promise in researching inflammation-related diseases. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN5881 |
4′-O-Isobutyroylpeguangxienin
|
||
4′-O-Isobutyroylpeguangxienin 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN5881,CAS号为 2188162-95-8。 |